Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 37001-37050 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06549582
Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients
NA
Not yet recruiting
160 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2026
5 conditions
1 sponsor
0 locations
NCT06456203
Trial of Artificial Intelligence for Chest Radiography
NA
Not yet recruiting
10,000 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2025
2 conditions
1 sponsor
0 locations
NCT06502106
Internet-delivered Trauma-focused Cognitive-behavioral Therapy as an Early Intervention After Sexual Trauma
NA
Not yet recruiting
30 participants
Started: Oct 31, 2024 · Completed: Oct 31, 2025
2 conditions
2 sponsors
1 location
NCT06227065
Precise Neoadjuvant Chemoresection of Low Grade NMIBC
PHASE2
Not yet recruiting
28 participants
Started: Oct 31, 2024 · Completed: Oct 31, 2029
3 conditions
2 sponsors
1 location
NCT06576037
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
PHASE1
Recruiting
128 participants
Started: Oct 31, 2024 · Completed: Jun 1, 2029
1 condition
1 sponsor
1 location
NCT06545149
SUPPLEMENTATION WITH BETA GLUCAN AND ADAPTATIVE RESPONSE.
NA
Not yet recruiting
44 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2025
1 condition
2 sponsors
0 locations
NCT06434207
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
N/A
Recruiting
10 participants
Started: Oct 31, 2024 · Completed: Dec 1, 2026
3 conditions
1 sponsor
1 location
NCT06131502
Sonication-based OCD Neurosurgical Intervention Via Capsulotomy
PHASE1/PHASE2
Not yet recruiting
66 participants
Started: Oct 31, 2024 · Completed: Jun 30, 2032
1 condition
2 sponsors
2 locations
NCT06626555
Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection
PHASE2
Not yet recruiting
36 participants
Started: Oct 31, 2024 · Completed: Mar 31, 2026
1 condition
2 sponsors
0 locations
NCT06694857
A Prospective Evaluation of the Filler for Jaw Contouring
PHASE4
Active, not recruiting
15 participants
Started: Oct 31, 2024 · Completed: Nov 1, 2025
1 condition
1 sponsor
1 location
NCT06434194
Serrantor OCT Study
NA
Recruiting
60 participants
Started: Oct 31, 2024 · Completed: Jun 1, 2025
1 condition
1 sponsor
2 locations
NCT06561659
Testing a Brief Exercise Intervention in Hoarding Disorder
NA
Not yet recruiting
22 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT06626646
Vascular Regenerative Cell Exhaustion in Adults with Peripheral Artery Disease (PAD-VRCE)
N/A
Recruiting
40 participants
Started: Oct 31, 2024 · Completed: Jul 31, 2025
4 conditions
1 sponsor
2 locations
NCT06628063
Examination of Pregnant Women in Third Trimester by Ultrasound to Detect Any Congenital Anomalies
N/A
Not yet recruiting
40 participants
Started: Oct 31, 2024 · Completed: Apr 30, 2025
1 condition
1 sponsor
0 locations
NCT06767254
A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence
N/A
Recruiting
200 participants
Started: Oct 30, 2024 · Completed: Aug 31, 2026
1 condition
1 sponsor
4 locations
NCT06503315
Genetic Polymorphism in Matrix Metalloproteinase 9 in Chronic Obstructive Pulmonary Disease in Sohag University Hospital.
N/A
Not yet recruiting
70 participants
Started: Oct 30, 2024 · Completed: Feb 24, 2026
1 condition
1 sponsor
1 location
NCT06595342
A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China
N/A
Not yet recruiting
60,000 participants
Started: Oct 30, 2024 · Completed: Jun 30, 2030
2 conditions
1 sponsor
1 location
NCT05283382
Cannabidiol Effects on Learning and Anxiety
EARLY_PHASE1
Recruiting
160 participants
Started: Oct 30, 2024 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT06679387
"The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients"
PHASE2
Recruiting
80 participants
Started: Oct 30, 2024 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06678685
Spironolactone Improved Children With NCOR Mutations
PHASE2/PHASE3
Not yet recruiting
3 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2025
3 conditions
1 sponsor
0 locations
NCT06621316
A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects
PHASE1/PHASE2
Active, not recruiting
74 participants
Started: Oct 30, 2024 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06558175
Reirradiation Dose Escalation in Thoracic Cancers
PHASE1
Not yet recruiting
48 participants
Started: Oct 30, 2024 · Completed: Jan 29, 2027
3 conditions
1 sponsor
0 locations
NCT06555744
A Study of ZW191 in Participants With Solid Tumors
PHASE1
Recruiting
145 participants
Started: Oct 30, 2024 · Completed: Jan 31, 2027
1 condition
1 sponsor
18 locations
NCT06020937
Olfactory and Trigeminal Functions in Patients With Multiple Sclerosis: Case-control Study
N/A
Not yet recruiting
200 participants
Started: Oct 30, 2024 · Completed: Dec 30, 2026
1 condition
4 sponsors
1 location
NCT06686108
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
PHASE2
Recruiting
59 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2028
3 conditions
1 sponsor
1 location
NCT06656403
Effect of Artificial Tears on Ocular Biometry Parameters
NA
Not yet recruiting
100 participants
Started: Oct 30, 2024 · Completed: Nov 21, 2024
2 conditions
1 sponsor
0 locations
NCT06642844
Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment
PHASE3
Not yet recruiting
244 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2029
1 condition
24 sponsors
0 locations
NCT06591468
A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics
PHASE2/PHASE3
Enrolling by invitation
244 participants
Started: Oct 30, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
2 locations
NCT06691152
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
PHASE1
Recruiting
18 participants
Started: Oct 30, 2024 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT06616038
Heart Failure Biomarkers
N/A
Not yet recruiting
114 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2025
2 conditions
1 sponsor
2 locations
NCT06541704
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
PHASE3
Recruiting
975 participants
Started: Oct 30, 2024 · Completed: May 21, 2032
2 conditions
1 sponsor
110 locations
NCT06972199
Reflexology Massage and Hot Water Foot Bath for Pain and GI Recovery After Colorectal Surgery
NA
Recruiting
102 participants
Started: Oct 30, 2024 · Completed: Jun 30, 2026
4 conditions
1 sponsor
2 locations
NCT06656234
The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
N/A
Not yet recruiting
200 participants
Started: Oct 30, 2024 · Completed: Sep 15, 2028
1 condition
1 sponsor
1 location
NCT06682572
A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients
PHASE2
Recruiting
15 participants
Started: Oct 30, 2024 · Completed: Oct 31, 2027
2 conditions
2 sponsors
5 locations
NCT06637813
Establishment of a Database of HIV Subjects Initiating or Simplifying Dual Therapy With Dolutegravir/Lamivudine
N/A
Not yet recruiting
1,220 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2034
1 condition
1 sponsor
0 locations
NCT06570278
Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NA
Recruiting
1,020 participants
Started: Oct 30, 2024 · Completed: Nov 30, 2034
1 condition
10 sponsors
26 locations
NCT06656949
Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer
NA
Recruiting
42 participants
Started: Oct 30, 2024 · Completed: Jan 30, 2026
1 condition
1 sponsor
1 location
NCT05993845
Modeling and Workflow Recognition for the Anterior Approach in Total Hip Arthroplasty
N/A
Recruiting
60 participants
Started: Oct 30, 2024 · Completed: Dec 30, 2025
1 condition
3 sponsors
3 locations
NCT06648213
Individual Structured Therapy in Early Premature Infants at the Neonatal Intensive Care Unit
NA
Active, not recruiting
20 participants
Started: Oct 30, 2024 · Completed: Jul 2, 2025
3 conditions
1 sponsor
1 location
NCT06633783
A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
PHASE3
Not yet recruiting
370 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2026
1 condition
1 sponsor
14 locations
NCT06601335
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
PHASE3
Recruiting
510 participants
Started: Oct 30, 2024 · Completed: Oct 31, 2027
1 condition
1 sponsor
2 locations
NCT06433219
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)
PHASE2
Active, not recruiting
63 participants
Started: Oct 30, 2024 · Completed: Jan 25, 2028
1 condition
2 sponsors
84 locations
NCT06361680
Effect of Coenzyme Q10 on Diabetic Children
EARLY_PHASE1
Not yet recruiting
100 participants
Started: Oct 30, 2024 · Completed: Nov 30, 2025
1 condition
1 sponsor
0 locations
NCT06689852
CLINICAL INVESTIGATION FOR THE EVALUATION OF EFFICACY AND SAFETY OF TWO PRODUCTS FOR THE TREATMENT OF ONYCHOMYCOSIS
NA
Recruiting
88 participants
Started: Oct 30, 2024 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT06464380
Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma
PHASE4
Not yet recruiting
40 participants
Started: Oct 30, 2024 · Completed: Oct 1, 2025
1 condition
6 sponsors
2 locations
NCT07169214
Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding
PHASE1
Recruiting
36 participants
Started: Oct 30, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06453512
A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema
NA
Recruiting
65 participants
Started: Oct 30, 2024 · Completed: Oct 1, 2025
1 condition
3 sponsors
1 location
NCT06621095
Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)
PHASE2
Not yet recruiting
104 participants
Started: Oct 30, 2024 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT06045858
Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2)
PHASE3
Not yet recruiting
178 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2027
2 conditions
1 sponsor
0 locations
NCT06561321
Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma
PHASE2
Recruiting
6 participants
Started: Oct 30, 2024 · Completed: Nov 1, 2026
1 condition
2 sponsors
1 location
Previous
1
More pages
738
739
740
741
742
743
744
More pages
2369
Next